Integrated Filing — IndAS



General information about company
Scrip Code 532660
NSE Symbol VIVIMEDLAB
MSEI Symbol NA
ISIN INE526G01021
Name of company Vivimed Labs Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 13-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment pharmaceuticals
Start date and time of board meeting 30-May-2025   16:00:00
End date and time of board meeting 30-May-2025   22:10:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 256140000 1162690000
Other income 42170000 43710000
Total income 298310000 1206400000
2 Expenses
(a) Cost of materials consumed 77590000 577610000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 36860000 20920000
(d) Employee benefit expense 87870000 283940000
(e) Finance costs 17400000 29470000
(f) Depreciation, depletion and amortisation expense
(f) Other Expenses
1 Other Expenses 78460000 410700000
2 Items that will not be reclassified to profit or loss, net of tax -4240000 -4240000
3 Items that will be reclassified to profit or loss, net of tax -390000 -390000
Total other expenses 73830000 406070000
Total expenses 348440000 1520250000
3 Total profit before exceptional items and tax
4 Exceptional items
5 Total profit before tax -50130000 -313850000
6 Tax expense
7 Current tax 2260000 2260000
8 Deferred tax -1130000 -1130000
9 Total tax expenses 1130000 1130000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement
11 Net Profit Loss for the period from continuing operations
12 Profit (loss) from discontinued operations before tax
13 Tax expense of discontinued operations
14 Net profit (loss) from discontinued operation after tax
15 Share of profit (loss) of associates and joint ventures accounted for using equity method
16 Total profit (loss) for period
17 Other comprehensive income net of taxes
18 Total Comprehensive Income for the period
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 165830000 165830000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 39080000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations
Diluted earnings (loss) per share from continuing operations
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations
Diluted earnings (loss) per share from discontinued operations
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.67 -3.85
Diluted earnings (loss) per share from continuing and discontinued operations -0.65 -3.74
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 2544030000
Capital work-in-progress
Investment property
Goodwill
Other intangible assets
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 1684950000
Trade receivables, non-current
Loans, non-current
Other non-current financial assets
Total non-current financial assets
Deferred tax assets (net) 0
Other non-current assets 0
Total non-current assets 5932790000
2 Current assets
Inventories 587550000
Current financial asset
Current investments 0
Trade receivables, current
Cash and cash equivalents 7080000
Bank balance other than cash and cash equivalents 0
Loans, current
Other current financial assets
Total current financial assets
Current tax assets (net)
Other current assets 985270000
Total current assets 3275550000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 9208340000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital
Other equity
Total equity attributable to owners of parent
Non controlling interest
Total equity
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total non-current financial liabilities
Provisions, non-current
Deferred tax liabilities (net) 86200000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 5478060000
Current liabilities
Current financial liabilities
Borrowings, current
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other current financial liabilities
Total current financial liabilities
Other current liabilities 545760000
Provisions, current
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 4081970000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities
Total equity and liabilites 9208340000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax -313850000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0
Adjustments for decrease (increase) in inventories 53070000
Adjustments for decrease (increase) in trade receivables, current
Adjustments for decrease (increase) in trade receivables, non-current
Adjustments for decrease (increase) in other current assets -73940000
Adjustments for decrease (increase) in other non-current assets
Adjustments for other financial assets, non-current
Adjustments for other financial assets, current
Adjustments for other bank balances
Adjustments for increase (decrease) in trade payables, current
Adjustments for increase (decrease) in trade payables, non-current
Adjustments for increase (decrease) in other current liabilities 46730000
Adjustments for increase (decrease) in other non-current liabilities
Adjustments for depreciation and amortisation expense 111700000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current
Adjustments for provisions, non-current
Adjustments for other financial liabilities, current
Adjustments for other financial liabilities, non-current
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income
Adjustments for share-based payments 0
Adjustments for fair value losses (gains)
Adjustments for undistributed profits of associates
Other adjustments for which cash effects are investing or financing cash flow 29470000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -2120000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 205720000
Net cash flows from (used in) operations -108130000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -108130000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment -45310000
Proceeds from sales of investment property
Purchase of investment property
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development
Purchase of intangible assets under development
Proceeds from sales of goodwill
Purchase of goodwill
Proceeds from biological assets other than bearer plants
Purchase of biological assets other than bearer plants
Proceeds from government grants 0
Proceeds from sales of other long-term assets
Purchase of other long-term assets
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) investing activities 45310000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries
Payments from changes in ownership interests in subsidiaries
Proceeds from issuing shares
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares
Payments of other equity instruments
Proceeds from exercise of stock options
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 80000000
Repayments of borrowings 890000
Payments of lease liabilities
Dividends paid 0
Interest paid 29470000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 49640000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -13180000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -13180000
Cash and cash equivalents cash flow statement at beginning of period 20260000
Cash and cash equivalents cash flow statement at end of period 7080000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Auditor's opinion Qualified opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 SVRL and CO Yes 30-Apr-2027


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income 1162690000 1162690000
2 Total Expenditure 1524880000 1524880000
3 Net Profit/(Loss) -319610000 -319610000
4 Earnings Per Share -3.85 -3.85
5 Total Assets 9208340000 9208340000
6 Total Liabilities 9208340000 9208340000
7 Net Worth -351690000 -351690000


Audit qualification
Sr. Details of Audit Qualification Type of Audit Qualification Frequency of qualification For Audit Qualification(s) where the impact is quantified by the auditor For Audit Qualification(s) where the impact is not quantified by the auditor
Management's Views (i) Management's estimation on the impact of audit qualification (ii) If management is unable to estimate the impact, reasons for the same Auditors' Comments on (i) or (ii) above


Text Block


Signatories detail
Name of CEO / Managing director SANTOSH VARLAWAR
Name of CFO PHANIDRANATH
Name of audit committee chairman SIVA PRASAD JARUGULA
Name of statutory auditor RAMA KRISHNA G
Name of other signatory, if any, with designation
Place hyderabad
Date 30-May-2025